REGENXBIO · 2 months ago
Senior Director/Director, Medical Science Liaisons (Neuromuscular/DMD)
United States
Full-time
Remote
Senior Level, Lead/Staff, Director/Executive
$206K/yr - $340K/yr
5+ years expREGENXBIO is an innovative company focused on developing gene therapy products. The Director of Medical Science Liaisons will build and lead MSL teams, develop field medical strategies, and support clinical development programs, particularly in neuromuscular diseases.
BiopharmaBiotechnologyGeneticsTherapeutics
Responsibilities
Design and build a high-functioning MSL organization including vision, territory design, strategic and tactical plans, resources and budgets
Collaborate with MA team members to develop therapeutic area and platform field strategies and tactics in support of MA goals
Recruit and coach / mentor MSLs for high performance including developing an MSL on-boarding scientific training program, content, and materials
Oversee thought leader mapping and KOL engagement strategy planning
Establish relationships with national thought leaders and investigators across therapeutic areas
Ensure development, and maintenance of resources for the MSL teams, including clinical and scientific communications, slide decks, educational materials, FAQs, publications, etc
Lead field insights, initiatives, and competitive intelligence activities and communicate key learnings to internal stakeholders
Provide clinical expertise and support of clinical trial recruitment / site outreach to support the Clinical Operations and Clinical Development teams
Attend medical conferences as MA representative, assist with congress strategy, planning and logistics, medical booth and meeting summaries
Maintain scientific and clinical knowledge in the therapeutic areas
Contribute to MA projects as assigned including advisory boards, natural history studies, etc
In this role, you will be required to travel 50%-70% of the time
Qualification
Required
Doctorate level or masters required (MD, PharmD, PhD, MPH or equivalent) with at least 5 years of MSL experience and 3 years MSL management experience
Therapeutic area expertise required in Duchenne Muscular Dystrophy or rare pediatric neuromuscular diseases
Demonstrated ability to lead and motivate people
Experience setting goals and leading field based medical affairs projects required
Superior communication, relationship building and interpersonal skills
Ability to assimilate new clinical data quickly
Proactive problem-solving skills
Project management and medical writing skills
Ability to organize and lead high level projects
Ability to proactively predict issues and solve problems
Flexible, resilient, resourceful, entrepreneurial, innovative, and conducts all activities in a highly ethical manner
Preferred
Experience in gene therapy
Benefits
Market-competitive salaries
Annual bonus program
Education assistance
Retirement plan with employer match
Stock options at all levels
Summer hours
Company
REGENXBIO
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
201-500 employees
Funding
Current Stage
Public CompanyTotal Funding
$928.19MKey Investors
Vivo Capital
2025-05-19Post Ipo Debt· $150M
2024-03-06Post Ipo Equity· $140M
2021-01-06Post Ipo Equity· $230.3M
Leadership Team
Curran Simpson
President and CEO
Francesca Cook
Vice President, Global Pricing and Market Access
Recent News
2026-01-16
Longevity.Technology
2026-01-16
Company data provided by crunchbase